Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure).

Stienen S, Ferreira JP, Kobayashi M, Preud'homme G, Dobre D, Machu JL, Duarte K, Bresso E, Devignes MD, López N, Girerd N, Aakhus S, Ambrosio G, Brunner-La Rocca HP, Fontes-Carvalho R, Fraser AG, van Heerebeek L, Heymans S, de Keulenaer G, Marino P, McDonald K, Mebazaa A, Papp Z, Raddino R, Tschöpe C, Paulus WJ, Zannad F, Rossignol P.

Biomarkers. 2020 Feb 16:1-11. doi: 10.1080/1354750X.2020.1727015. [Epub ahead of print]

PMID:
32063068
2.

Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort.

Xhaard C, Dandine-Roulland C, Villemereuil P, Floch EL, Bacq-Daian D, Machu JL, Ferreira JP, Deleuze JF, Zannad F, Rossignol P, Girerd N.

Eur J Prev Cardiol. 2019 Dec 2:2047487319890763. doi: 10.1177/2047487319890763. [Epub ahead of print]

PMID:
31791143
3.

Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses.

Ferreira JP, Pizard A, Machu JL, Bresso E, Rocca HB, Girerd N, Leroy C, González A, Diez J, Heymans S, Devignes MD, Rossignol P, Zannad F; FIBRO-TARGETS investigators.

Clin Res Cardiol. 2020 Jan;109(1):22-33. doi: 10.1007/s00392-019-01480-4. Epub 2019 May 6.

PMID:
31062082
4.

Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study).

Lopez-Sublet M, Girerd N, Bozec E, Machu JL, Ferreira JP, Zannad F, Mourad JJ, Rossignol P.

Am J Hypertens. 2019 Jun 11;32(7):620-628. doi: 10.1093/ajh/hpz020.

PMID:
30753257
5.

Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure.

Ferreira JP, Rossignol P, Pizard A, Machu JL, Collier T, Girerd N, Huby AC, Gonzalez A, Diez J, López B, Sattar N, Cleland JG, Sever PS, Zannad F.

Heart. 2019 Feb;105(4):307-314. doi: 10.1136/heartjnl-2018-313182. Epub 2018 Aug 18.

6.

Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France.

Ferreira JP, Girerd N, Bozec E, Mercklé L, Pizard A, Bouali S, Eby E, Leroy C, Machu JL, Boivin JM, Lamiral Z, Rossignol P, Zannad F.

Int J Epidemiol. 2018 Apr 1;47(2):395-395j. doi: 10.1093/ije/dyx240. No abstract available.

PMID:
29220499
7.

Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.

Ferreira JP, Machu JL, Girerd N, Jaisser F, Thum T, Butler J, González A, Diez J, Heymans S, McDonald K, Gyöngyösi M, Firat H, Rossignol P, Pizard A, Zannad F.

ESC Heart Fail. 2018 Feb;5(1):139-148. doi: 10.1002/ehf2.12218. Epub 2017 Oct 7. Review.

8.

Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative.

Agewall S, Tjessem LH, Rossignol P, Zannad F, Atar D, Lamiral Z, Machu JL, Dickstein K, Kjekshus J, von Lueder TG, Girerd N; High Risk Myocardial Infarction Database Initiative investigators.

Int J Cardiol. 2017 Dec 15;249:274-281. doi: 10.1016/j.ijcard.2017.09.182. Epub 2017 Sep 24.

PMID:
28964557
9.

Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary Management.

Chagot C, Blonski M, Machu JL, Bracard S, Lacour JC, Richard S.

J Obes. 2017;2017:5348928. doi: 10.1155/2017/5348928. Epub 2017 Aug 13.

10.

Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.

Ferreira JP, Rossignol P, Machu JL, Sharma A, Girerd N, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, Lang CC, Ter Maaten JM, Metra M, Ng L, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zwinderman AH, Voors A, Zannad F.

Eur J Heart Fail. 2017 Oct;19(10):1284-1293. doi: 10.1002/ejhf.900. Epub 2017 Jun 5.

11.

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial.

Olivier A, Pitt B, Girerd N, Lamiral Z, Machu JL, McMurray JJV, Swedberg K, van Veldhuisen DJ, Collier TJ, Pocock SJ, Rossignol P, Zannad F, Pizard A.

Eur J Heart Fail. 2017 Sep;19(9):1186-1197. doi: 10.1002/ejhf.792. Epub 2017 Mar 16.

12.

Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study).

Ferreira JP, Girerd N, Bozec E, Machu JL, Boivin JM, London GM, Zannad F, Rossignol P.

J Am Heart Assoc. 2016 Jun 16;5(6). pii: e003529. doi: 10.1161/JAHA.116.003529.

13.

[Parental representations of children's cough and expectations on its management].

Ventaja G, Steyer E, Machu JL, Boivin JM.

Arch Pediatr. 2016 Apr;23(4):348-52. doi: 10.1016/j.arcped.2016.01.010. Epub 2016 Mar 9. French.

PMID:
26971137

Supplemental Content

Support Center